Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.

 

Cleveland Clinic Taussig Cancer Institute
Avatar

Rationale and Early Results of Innate Immunity and Immune Check Point Blockade in the Treatment of MDS

By Cleveland Clinic Taussig Cancer Institute FEATURING Guillermo Garcia-Manero
By Cleveland Clinic Taussig Cancer Institute FEATURING Guillermo Garcia-Manero
117 views
December 12, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

11:11
Lilly Medical Affairs

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
MDS/MPN
10:06

New Therapeutic Targets Beyond JAK-STAT Inhibition in the Treatment …

Cleveland Clinic Taussig Cancer Institute

A. Gerds

399 views
16:58

JAK-STAT Inhibition in the Treatment of Ph-Negative MPN: What Are th…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

264 views
30:31

Somatic Mutations in MDS as a Diagnostic (ICUS, CHIP, CCUS) and Prog…

Cleveland Clinic Taussig Cancer Institute

V. Santini

140 views
28:01

The Changing Genomic Landscape of MPNs: Impact on Clinical Care

Cleveland Clinic Taussig Cancer Institute

L. Michaelis

162 views
07:40

MPN, MDS and Aplastic Anemia Case Discussions

Cleveland Clinic Taussig Cancer Institute

L. Michaelis

426 views
28:08

Rationale and Early Results of Innate Immunity and Immune Check Poin…

Cleveland Clinic Taussig Cancer Institute

G. Garcia-Manero

117 views
14:50

Novel Therapies Beyond Single Agent JAK Inhibitors: New Therapies an…

Cleveland Clinic Taussig Cancer Institute

A. Gerds

302 views